AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. It sells its products through direct sales force in the US and through a network of distributors outside the US, which include Europe, Asia, Latin America and others. AngioDynamics is headquartered in Latham, New York, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company AngioDynamics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- AngioDynamics Inc Company Overview
- AngioDynamics Inc Company Snapshot
- AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- AngioDynamics Inc - Pipeline Analysis Overview
- Business Description
- AngioDynamics Inc - Key Facts
- AngioDynamics Inc - Major Products and Services
- AngioDynamics Inc Pipeline Products by Development Stage
- AngioDynamics Inc Ongoing Clinical Trials by Trial Status
- AngioDynamics Inc Pipeline Products Overview
- Acuswift
- Acuswift Product Overview
- Adx
- Adx Product Overview
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Product Overview
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System Clinical Trial
- Alphavac System - Infective Endocarditis
- Alphavac System - Infective Endocarditis Product Overview
- Alphavac System - Left Atrial Appendage Thrombus
- Alphavac System - Left Atrial Appendage Thrombus Product Overview
- AngioVac - Generation 4
- AngioVac - Generation 4 Product Overview
- AngioVac - Left Heart
- AngioVac - Left Heart Product Overview
- AngioVac Low Profile Catheter
- AngioVac Low Profile Catheter Product Overview
- AURYON Atherectomy System - CAD
- AURYON Atherectomy System - CAD Product Overview
- AURYON Atherectomy System - Gastrointestinal Procedures
- AURYON Atherectomy System - Gastrointestinal Procedures Product Overview
- AURYON Atherectomy System - Iliofemoral DVT
- AURYON Atherectomy System - Iliofemoral DVT Product Overview
- AURYON Atherectomy System - Lead Extraction
- AURYON Atherectomy System - Lead Extraction Product Overview
- AURYON Atherectomy System - Venous Disease
- AURYON Atherectomy System - Venous Disease Product Overview
- AURYON System - Small Vessel Thrombectomy
- AURYON System - Small Vessel Thrombectomy Product Overview
- Automated Fluid Management System
- Automated Fluid Management System Product Overview
- BioFlo PICC Line Extension
- BioFlo PICC Line Extension Product Overview
- BioFlo Portline Line Extension
- BioFlo Portline Line Extension Product Overview
- Coronary Angio Catheter
- Coronary Angio Catheter Product Overview
- FireFly Tip Location
- FireFly Tip Location Product Overview
- Inflation Device
- Inflation Device Product Overview
- Mechanical Thrombectomy Device
- Mechanical Thrombectomy Device Product Overview
- Multi-Purpose Mechanical Aspiration - F1885 PE
- Multi-Purpose Mechanical Aspiration - F1885 PE Product Overview
- Multi-Purpose Mechanical Aspiration Gen 2
- Multi-Purpose Mechanical Aspiration Gen 2 Product Overview
- NanoKnife 3.0 System - Liver Cancer
- NanoKnife 3.0 System - Liver Cancer Product Overview
- NanoKnife 3.0 System - Pancreatic Cancer
- NanoKnife 3.0 System - Pancreatic Cancer Product Overview
- NanoKnife 3.0 System - Prostate Cancer
- NanoKnife 3.0 System - Prostate Cancer Product Overview
- Nanoknife System - Bladder Cancer
- Nanoknife System - Bladder Cancer Product Overview
- NanoKnife System - Cervical Cancer
- NanoKnife System - Cervical Cancer Product Overview
- NanoKnife System - Head And Neck Cancer
- NanoKnife System - Head And Neck Cancer Product Overview
- NanoKnife System - Hepatocellular Carcinoma
- NanoKnife System - Hepatocellular Carcinoma Product Overview
- NanoKnife System - Lung Cancer
- NanoKnife System - Lung Cancer Product Overview
- NanoKnife System - Lung Cancer Clinical Trial
- Nanoknife System - Metastatic Lymph Nodes
- Nanoknife System - Metastatic Lymph Nodes Product Overview
- NanoKnife System - Prostate Cancer
- NanoKnife System - Prostate Cancer Product Overview
- NanoKnife System - Prostate Cancer Clinical Trial
- NanoKnife System - Rectal Cancer
- NanoKnife System - Rectal Cancer Product Overview
- Nanoknife System - Renal Pelvis Urothelial Neoplasms
- Nanoknife System - Renal Pelvis Urothelial Neoplasms Product Overview
- NanoKnife System - Stage III Pancreatic Cancer
- NanoKnife System - Stage III Pancreatic Cancer Product Overview
- NanoKnife System - Stage III Pancreatic Cancer Clinical Trial
- Nanoknife System - Stomach Neoplasm
- Nanoknife System - Stomach Neoplasm Product Overview
- Next Gen Tumescent Delivery Device
- Next Gen Tumescent Delivery Device Product Overview
- Next Generation BioFlo PICC
- Next Generation BioFlo PICC Product Overview
- Next Generation BioFlo Port
- Next Generation BioFlo Port Product Overview
- Next Generation Dialysis Device
- Next Generation Dialysis Device Product Overview
- Next Generation Laser
- Next Generation Laser Product Overview
- Next Generation Radio Frequency Ablation System
- Next Generation Radio Frequency Ablation System Product Overview
- Non-Thermal Vein Ablation Device
- Non-Thermal Vein Ablation Device Product Overview
- Peripheral Vascular Drainage Line Extension
- Peripheral Vascular Drainage Line Extension Product Overview
- POWERWAVE
- POWERWAVE Product Overview
- RadiaDyne Endorectal Balloon Device
- RadiaDyne Endorectal Balloon Device Product Overview
- Smart Port - Dual
- Smart Port - Dual Product Overview
- Ultrasound-Assisted Thrombectomy System
- Ultrasound-Assisted Thrombectomy System Product Overview
- AngioDynamics Inc - Key Competitors
- AngioDynamics Inc - Key Employees
- AngioDynamics Inc - Key Employee Biographies
- AngioDynamics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- AngioDynamics Inc, Recent Developments
- Apr 13, 2023: AngioDynamics and Cardiva expand partnership to bring life-saving products to more patients in Europe
- Mar 30, 2023: AngioDynamics announces exciting new partnership with Minimax Medical
- Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results
- Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance
- Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference
- Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference
- Jun 23, 2020: AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020
- Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
- Jan 17, 2020: AngioDynamics begins study on Auryon atherectomy system
- Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- AngioDynamics Inc Pipeline Products and Ongoing Clinical Trials Overview
- AngioDynamics Inc Pipeline Products by Equipment Type
- AngioDynamics Inc Pipeline Products by Indication
- AngioDynamics Inc Ongoing Clinical Trials by Trial Status
- AngioDynamics Inc, Key Facts
- AngioDynamics Inc, Major Products and Services
- AngioDynamics Inc Number of Pipeline Products by Development Stage
- AngioDynamics Inc Pipeline Products Summary by Development Stage
- AngioDynamics Inc Ongoing Clinical Trials by Trial Status
- AngioDynamics Inc Ongoing Clinical Trials Summary
- Acuswift - Product Status
- Acuswift - Product Description
- Adx - Product Status
- Adx - Product Description
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Status
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Product Description
- AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System - Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism
- Alphavac System - Infective Endocarditis - Product Status
- Alphavac System - Infective Endocarditis - Product Description
- Alphavac System - Left Atrial Appendage Thrombus - Product Status
- Alphavac System - Left Atrial Appendage Thrombus - Product Description
- AngioVac - Generation 4 - Product Status
- AngioVac - Generation 4 - Product Description
- AngioVac - Left Heart - Product Status
- AngioVac - Left Heart - Product Description
- AngioVac Low Profile Catheter - Product Status
- AngioVac Low Profile Catheter - Product Description
- AURYON Atherectomy System - CAD - Product Status
- AURYON Atherectomy System - CAD - Prod
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teleflex Inc
- CR Bard Inc
- Medtronic Plc
- Smiths Medical
- Total Vein Systems
- Cook Medical Inc
- Boston Scientific Corp
- Johnson & Johnson
- Merit Medical Systems Inc
- Terumo Medical Corp
